Infection of Mice with Mycobacterium Bovis-Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1998 Mar 28

PMID 9463406

Citations 96

Authors

K J Erb

J W Holloway

A Sobeck

H Moll

G Le Gros

Affiliations

Soon will be listed here.

Abstract

It has been proposed that the increase in prevalence and severity of atopic disorders inversely correlates with exposure to infectious diseases such as tuberculosis. We have investigated this issue by combining an intranasal Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) infection with a murine model of allergen, (ovalbumin [OVA]) induced airway eosinophilia. BCG infection either 4 or 12 wk before allergen airway challenge resulted in a 90-95 and 60-70% reduction in eosinophilia within the lungs, respectively, compared to uninfected controls. The inhibition of airway eosinophilia correlated with a reduced level of IL-5 production by T cells from the lymph node draining the site of OVA challenge. Interestingly, BCG infection of the lung had no effect on IgG1 and IgE OVA-specific serum immunoglobulin or blood eosinophil levels. Furthermore, BCG-induced inhibition of airway eosinophilia was strongly reduced in interferon (IFN)-gamma receptor-deficient mice and could be partially reversed by intranasal IL-5 application. Intranasal BCG infections could also reduce the degree of lung eosinophilia and IL-5 produced by T cells after Nippostrongylus brasiliensis infection. Taken together, our data suggest that IFN-gamma produced during the T helper cell (Th)1 immune response against BCG suppresses the development of local inflammatory Th2 responses in the lung. Most importantly, this inhibition did not extend to the systemic immunoglobulin response against OVA. Our data support the view that mycobacterial infections have the potential to suppress the development of atopic disorders in humans.

Citing Articles

Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC.

Calvo S, Rodrigo-Munoz J, Tarancon R, Uranga S, Martin C, Del Pozo V EBioMedicine. 2024; 107:105272.

PMID: 39173529 PMC: 11387674. DOI: 10.1016/j.ebiom.2024.105272.

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.

Derre L, Lucca I, Cesson V, Bohner P, Crettenand F, Rodrigues-Dias S J Immunother Cancer. 2023; 11(12).

PMID: 38101861 PMC: 10729085. DOI: 10.1136/jitc-2023-008020.

Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.

Weinberg M, Zafar A, Magdamo C, Chung S, Chou W, Nayan M JAMA Netw Open. 2023; 6(5):e2314336.

PMID: 37204792 PMC: 10199345. DOI: 10.1001/jamanetworkopen.2023.14336.

Suppression of Allergic Asthma by Loss of Function of Miz1-mediated Th1 Skewing.

Do-Umehara H, Chen C, Zhang Q, Schleimer R, Budinger G, Liu J Am J Respir Cell Mol Biol. 2022; 67(3):346-359.

PMID: 35833903 PMC: 9447135. DOI: 10.1165/rcmb.2022-0135OC.

Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation.

Cautivo K, Matatia P, Lizama C, Mroz N, Dahlgren M, Yu X Immunity. 2022; 55(2):254-271.e7.

PMID: 35139352 PMC: 8852844. DOI: 10.1016/j.immuni.2021.12.014.

References

Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni M . IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol. 1992; 149(9):2977-83. View

Sher A, Gazzinelli R, Oswald I, Clerici M, Kullberg M, Pearce E . Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev. 1992; 127:183-204. DOI: 10.1111/j.1600-065x.1992.tb01414.x. View

Del Prete G . Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 1992; 47(5):450-5. DOI: 10.1111/j.1398-9995.1992.tb00662.x. View

Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R . Immune response in mice that lack the interferon-gamma receptor. Science. 1993; 259(5102):1742-5. DOI: 10.1126/science.8456301. View

Kopf M, Le Gros G, Bachmann M, Lamers M, Bluethmann H, Kohler G . Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993; 362(6417):245-8. DOI: 10.1038/362245a0. View

Kaufmann S . Immunity to intracellular bacteria. Annu Rev Immunol. 1993; 11:129-63. DOI: 10.1146/annurev.iy.11.040193.001021. View

Orme I, Andersen P, Boom W . T cell response to Mycobacterium tuberculosis. J Infect Dis. 1993; 167(6):1481-97. DOI: 10.1093/infdis/167.6.1481. View

Seaton A, Godden D, Brown K . Increase in asthma: a more toxic environment or a more susceptible population?. Thorax. 1994; 49(2):171-4. PMC: 474339. DOI: 10.1136/thx.49.2.171. View

Wang Z, Reiner S, Zheng S, Dalton D, Locksley R . CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med. 1994; 179(4):1367-71. PMC: 2191434. DOI: 10.1084/jem.179.4.1367. View

10.

Donckier V, Abramowicz D, Bruyns C, Florquin S, Vanderhaeghen M, Amraoui Z . IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol. 1994; 153(6):2361-8. View

11.

Braback L, Breborowicz A, Dreborg S, Knutsson A, Pieklik H, Bjorksten B . Atopic sensitization and respiratory symptoms among Polish and Swedish school children. Clin Exp Allergy. 1994; 24(9):826-35. DOI: 10.1111/j.1365-2222.1994.tb01805.x. View

12.

Gavett S, OHearn D, Li X, Huang S, Finkelman F, Wills-Karp M . Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med. 1995; 182(5):1527-36. PMC: 2192202. DOI: 10.1084/jem.182.5.1527. View

13.

Foster P, Hogan S, Ramsay A, Matthaei K, Young I . Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996; 183(1):195-201. PMC: 2192412. DOI: 10.1084/jem.183.1.195. View

14.

Kopf M, Brombacher F, Hodgkin P, Ramsay A, Milbourne E, Dai W . IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996; 4(1):15-24. DOI: 10.1016/s1074-7613(00)80294-0. View

15.

Fearon D, Locksley R . The instructive role of innate immunity in the acquired immune response. Science. 1996; 272(5258):50-3. DOI: 10.1126/science.272.5258.50. View

16.

Erb K, Le Gros G . The role of Th2 type CD4+ T cells and Th2 type CD8+ T cells in asthma. Immunol Cell Biol. 1996; 74(2):206-8. DOI: 10.1038/icb.1996.29. View

17.

Lack G, Bradley K, Hamelmann E, Renz H, Loader J, Leung D . Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol. 1996; 157(4):1432-9. View

18.

Carter L, Dutton R . Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol. 1996; 8(3):336-42. DOI: 10.1016/s0952-7915(96)80122-1. View

19.

Li X, Chopra R, Chou T, Schofield B, Wills-Karp M, Huang S . Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol. 1996; 157(8):3216-9. View

20.

MacLean J, Ownbey R, Luster A . T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med. 1996; 184(4):1461-9. PMC: 2192832. DOI: 10.1084/jem.184.4.1461. View